VERTEX PHARMACEUTICALS INC / MA
VRTX · Nasdaq · CIK 0000875320
SIC 2834
Pharmaceutical Preparations
Category
Chemicals
Entity
operating
Incorp.
MA
Fiscal Y/E
1231
Source: SEC EDGAR · All filings on SEC →
Investment Indicators
ROE
21.18%
ROA
15.42%
D/E Ratio
0.37
Current Ratio
2.90
Operating Margin
167.69%
Net Margin
158.85%
Book Value/Share
$73.49
Financial Statements
In USD millions (per-share figures shown directly) · Financials as of: 2026-02-13
Income Statement
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cost of Revenue | 1,651 | 1,531 | 1,262 | 1,080 | 904 |
| Operating Income | 4,173 | -233 | 3,832 | 4,307 | 2,782 |
| Net Income | 3,953 | -536 | 3,620 | 3,322 | 2,342 |
| EPS (Basic) | 15.46 | -2.08 | 14.05 | 12.97 | 9.09 |
| EPS (Diluted) | 15.32 | -2.08 | 13.89 | 12.82 | 9.01 |
Balance Sheet
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total Assets | 25,643 | 22,533 | 22,730 | 18,151 | 13,433 |
| Current Assets | 11,201 | 9,596 | 14,144 | 13,235 | 9,561 |
| Cash & Equivalents | 5,085 | 4,570 | 10,369 | 10,504 | 6,795 |
| Total Liabilities | 6,977 | 6,124 | 5,150 | 4,238 | 3,333 |
| Current Liabilities | 3,861 | 3,565 | 3,547 | 2,742 | 2,142 |
| Total Equity | 18,666 | 16,410 | 17,580 | 13,913 | 10,100 |
Cash Flow
| FY | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating CF | 3,631 | -493 | 3,537 | 4,130 | 2,644 |
| Investing CF | -945 | -3,770 | -3,142 | -321 | -341 |
| Financing CF | -2,261 | -1,495 | -562 | -68 | -1,478 |
| CapEx | 438 | 298 | 200 | 205 | 235 |
📄 SEC Filings
Current Report
8-K
2026-05-13
Open →
Quarterly Report
10-Q
2026-05-05
Open →
Current Report
8-K
2026-05-04
Open →
Current Report
8-K
2026-04-29
Open →
Proxy Statement
DEF 14A
2026-04-02
Open →
Current Report
8-K
2026-03-31
Open →
Other filings (94)
Insider Transaction
FORM 4
2026-05-14
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-05-14
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-05-14
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8 POS
S-8 POS
2026-05-13
Open →
S-8
S-8
2026-05-13
Open →
144
xsl144X01/primary_doc.xml
2026-05-12
Open →
144
xsl144X01/primary_doc.xml
2026-05-06
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
Insider Transaction
FORM 4
2026-05-05
Open →
144
xsl144X01/primary_doc.xml
2026-05-04
Open →
144
xsl144X01/primary_doc.xml
2026-05-01
Open →
SCHEDULE 13G
xslSCHEDULE_13G_X02/primary_doc.xml
2026-04-30
Open →
DEFA14A
DEFA14A
2026-04-29
Open →
Insider Transaction
FORM 4
2026-04-17
Open →
Insider Transaction
FORM 4
2026-04-17
Open →
Insider Transaction
FORM 4
2026-04-17
Open →
UPLOAD
filename1.pdf
2026-04-14
Open →
Insider Transaction
FORM 4
2026-04-03
Open →
ARS
ARS
2026-04-02
Open →
DEFA14A
DEFA14A
2026-04-02
Open →
144
xsl144X01/primary_doc.xml
2026-04-01
Open →
CORRESP
filename1.htm
2026-04-01
Open →
Insider Transaction
FORM 4
2026-03-31
Open →
SCHEDULE 13G/A
xslSCHEDULE_13G_X02/primary_doc.xml
2026-03-27
Open →
144
xsl144X01/primary_doc.xml
2026-03-27
Open →
UPLOAD
filename1.pdf
2026-03-18
Open →
Insider Transaction
FORM 4
2026-03-17
Open →
Insider Transaction
FORM 4
2026-03-13
Open →
144
xsl144X01/primary_doc.xml
2026-03-13
Open →
144
xsl144X01/primary_doc.xml
2026-03-11
Open →
Insider Transaction
FORM 4
2026-03-06
Open →
Insider Transaction
FORM 4
2026-03-04
Open →
144
xsl144X01/primary_doc.xml
2026-03-04
Open →
3
FORM 3
2026-03-03
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
Insider Transaction
FORM 4
2026-03-03
Open →
144
xsl144X01/primary_doc.xml
2026-03-02
Open →
Insider Transaction
FORM 4
2026-03-02
Open →
144
xsl144X01/primary_doc.xml
2026-02-27
Open →
144
xsl144X01/primary_doc.xml
2026-02-27
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
Insider Transaction
FORM 4
2026-02-26
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
144
xsl144X01/primary_doc.xml
2026-02-25
Open →
Insider Transaction
FORM 4
2026-02-23
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
144
xsl144X01/primary_doc.xml
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-19
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →
Insider Transaction
FORM 4
2026-02-18
Open →